Production of Prozac, an antidepressant, would end globally at the end of this year, drugmaker Eli Lilly and Co said in a press release yesterday after announcing in August that the drug would soon be ...
They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...
The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...
Although medications in this class are called antidepressants, they have effects that go beyond stabilizing a depressed mood. Antidepressants have been shown to affect many aspects of the body, ...
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.